Shares of Johnson & Johnson /zigman2/quotes/201724570/composite JNJ +1.38% sank 0.54% to $162.85 Thursday, on what proved to be an all-around positive trading session for the stock market, with the S&P 500 Index /zigman2/quotes/210599714/realtime SPX -1.18% rising 0.98% to 4,596.42 and the Dow Jones Industrial Average /zigman2/quotes/210598065/realtime DJIA -1.34% rising 0.68% to 35,730.48. This was the stock's second consecutive day of losses. Johnson & Johnson closed $17.07 below its 52-week high ($179.92), which the company achieved on August 20th.
The stock underperformed when compared to some of its competitors Thursday, as Roche Holding AG Part. Cert. /zigman2/quotes/206948568/composite RHHVF +3.79% rose 1.56% to $391.00, Merck & Co. Inc. /zigman2/quotes/209956077/composite MRK -0.63% rose 6.14% to $86.55, and Pfizer Inc. /zigman2/quotes/202877789/composite PFE +1.77% rose 0.49% to $43.18. Trading volume (6.3 M) eclipsed its 50-day average volume of 6.1 M.